We’ve done the sums and PIOP is a lucrative $150bn+ project , with the latest offer on the table there is nothing stopping BBIG to sell it on if an offer were to come along.
“An offer they couldn’t refuse”
The maturation data would serve well in a sale.
GLTA
- Forums
- ASX - By Stock
- 12 years ago
We’ve done the sums and PIOP is a lucrative $150bn+ project ,...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHK (ASX) to my watchlist
|
|||||
Last
84.5¢ |
Change
0.040(4.97%) |
Mkt cap ! $168.8M |
Open | High | Low | Value | Volume |
84.5¢ | 84.5¢ | 84.5¢ | $95 | 112 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 80.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
88.0¢ | 10355 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 0.805 |
1 | 3035 | 0.800 |
1 | 2531 | 0.770 |
1 | 16200 | 0.760 |
2 | 5573 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.880 | 10355 | 1 |
0.890 | 2368 | 1 |
0.910 | 20000 | 1 |
0.980 | 10000 | 1 |
1.000 | 1812 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RHK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online